Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2004 2
2006 1
2007 1
2008 2
2009 2
2010 1
2013 1
2014 2
2015 3
2016 2
2018 4
2019 6
2021 3
2022 1
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023.
Peris K, Fargnoli MC, Kaufmann R, Arenberger P, Bastholt L, Seguin NB, Bataille V, Brochez L, Del Marmol V, Dummer R, Forsea AM, Gaudy-Marqueste C, Harwood CA, Hauschild A, Höller C, Kandolf L, Kellerners-Smeets NWJ, Lallas A, Leiter U, Malvehy J, Marinović B, Mijuskovic Z, Moreno-Ramirez D, Nagore E, Nathan P, Stratigos AJ, Stockfleth E, Tagliaferri L, Trakatelli M, Vieira R, Zalaudek I, Garbe C; EADO”A, EDF”B, ESTRO”C, UEMS”D and EADV”E. Peris K, et al. Among authors: nagore e. Eur J Cancer. 2023 Oct;192:113254. doi: 10.1016/j.ejca.2023.113254. Epub 2023 Jul 28. Eur J Cancer. 2023. PMID: 37604067 Free article. Review.
Update on Lentigo Maligna: Diagnostic Signs and Treatment.
Requena C, Manrique E, Nagore E. Requena C, et al. Among authors: nagore e. Actas Dermosifiliogr. 2023 May;114(5):413-424. doi: 10.1016/j.ad.2023.02.019. Epub 2023 Mar 15. Actas Dermosifiliogr. 2023. PMID: 36925098 Free article. Review. English, Spanish.
Current Situation of Skin Cancer in Spain.
Nagore E, Moreno-Ramírez D. Nagore E, et al. Actas Dermosifiliogr. 2016 May;107(4):267-8. doi: 10.1016/j.ad.2016.04.001. Actas Dermosifiliogr. 2016. PMID: 27131045 Free article. English, Spanish. No abstract available.
TERT promoter mutations and melanoma survival: A comprehensive literature review and meta-analysis.
Gandini S, Zanna I, De Angelis S, Palli D, Raimondi S, Ribero S, Masala G, Suppa M, Bellerba F, Corso F, Nezi L, Nagore E, Caini S. Gandini S, et al. Among authors: nagore e. Crit Rev Oncol Hematol. 2021 Apr;160:103288. doi: 10.1016/j.critrevonc.2021.103288. Epub 2021 Mar 3. Crit Rev Oncol Hematol. 2021. PMID: 33675908 Review.
Limited, yet suggestive evidence of a detrimental effect of TERT promoter mutations on melanoma prognosis emerged also for other survival measures (e.g. disease-free and distant metastasis-free survival). We found suggestive evidence of a detrimental effect of TERT mutatio …
Limited, yet suggestive evidence of a detrimental effect of TERT promoter mutations on melanoma prognosis emerged also for other survival me …
[CONSORT, STROBE, and STARD. Tools to improve the reporting of research].
Moreno-Ramírez D, Arias-Santiago S, Nagore E, Gilaberte Y. Moreno-Ramírez D, et al. Among authors: nagore e. Actas Dermosifiliogr. 2015 Mar;106(2):79-81. doi: 10.1016/j.ad.2014.11.003. Epub 2014 Dec 17. Actas Dermosifiliogr. 2015. PMID: 25528525 Free article. Spanish. No abstract available.
High- and intermediate-risk susceptibility variants in melanoma families from the Mediterranean area: A multicentre cohort from the MelaNostrum Consortium.
Pellegrini C, Cardelli L, Ghiorzo P, Pastorino L, Potrony M, García-Casado Z, Elefanti L, Stefanaki I, Mastrangelo M, Necozione S, Aguilera P, Rodríguez-Hernández A, Di Nardo L, Rocco T, Del Regno L, Badenas C, Carrera C, Malvehy J, Requena C, Bañuls J, Stratigos AJ, Peris K, Menin C, Calista D, Nagore E, Puig S, Landi MT, Fargnoli MC. Pellegrini C, et al. Among authors: nagore e. J Eur Acad Dermatol Venereol. 2023 Dec;37(12):2498-2508. doi: 10.1111/jdv.19461. Epub 2023 Sep 5. J Eur Acad Dermatol Venereol. 2023. PMID: 37611275
Frequent DPH3 promoter mutations in skin cancers.
Denisova E, Heidenreich B, Nagore E, Rachakonda PS, Hosen I, Akrap I, Traves V, García-Casado Z, López-Guerrero JA, Requena C, Sanmartin O, Serra-Guillén C, Llombart B, Guillén C, Ferrando J, Gimeno E, Nordheim A, Hemminki K, Kumar R. Denisova E, et al. Among authors: nagore e. Oncotarget. 2015 Nov 3;6(34):35922-30. doi: 10.18632/oncotarget.5771. Oncotarget. 2015. PMID: 26416425 Free PMC article.
The UV-signature mutations occurred at sites adjacent and within a binding motif for E-twenty six/ternary complex factors (Ets/TCF), at -8 and -9 bp from DPH3 transcription start site. ...
The UV-signature mutations occurred at sites adjacent and within a binding motif for E-twenty six/ternary complex factors (Ets/TCF), …
Telomere length, telomerase reverse transcriptase promoter mutations, and melanoma risk.
Rachakonda S, Kong H, Srinivas N, Garcia-Casado Z, Requena C, Fallah M, Heidenreich B, Planelles D, Traves V, Schadendorf D, Nagore E, Kumar R. Rachakonda S, et al. Among authors: nagore e. Genes Chromosomes Cancer. 2018 Nov;57(11):564-572. doi: 10.1002/gcc.22669. Epub 2018 Sep 11. Genes Chromosomes Cancer. 2018. PMID: 30203894
The mutation causes increased TERT and telomerase levels through creation of a binding motif for E-twenty six (ETS) transcription factors and the carriers develop melanoma with an early age of onset and rapid progression to metastasis. ...
The mutation causes increased TERT and telomerase levels through creation of a binding motif for E-twenty six (ETS) transcription fac …
33 results